PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 

Expect Advertising, Inc.

Press Release


Receive press releases from Expect Advertising, Inc.: By Email RSS Feeds:
White Paper: The Hazards of Unapproved Drugs and Importance of Utilizing Approved Drugs

“Continued use of non-approved drugs when a safe, FDA-approved product is available is not in the public interest and can lead to legal lawsuits.” -Cindy Ippoliti, Pharm.D., NYP/Weill Cornell

Clifton, NJ, March 17, 2014 --(PR.com)-- In an ongoing effort to promote the usage of FDA-approved drugs, Medicast, Inc., a medical education organization, has released a White Paper — The Hazards of Unapproved Drugs and Importance of Utilizing Approved Drugs.

The White Paper was developed by a leading hospital pharmacist – Cindy Ippoliti, Pharm.D., NYP/Weill Cornell, who advocates the use of safe and effective FDA-approved drugs. Cindy was assisted by Christan Thomas, Pharm.D. and Frank Cirrone, Pharm.D., NYP/Weill Cornell.

Each year dozens of drugs that are proven to be safe and effective are approved by the US Food and Drug Administration (FDA). However, many unapproved products remain on the market, “grandfathered” by older regulations. The FDA has expressed serious concerns that drugs marketed without the required FDA approvals may not meet modern standards for safety, effectiveness, quality and labeling. In recognition of this issue, the FDA launched a safety initiative in 2006 with the goal of removing unapproved drugs from the market.

“The use of unapproved drugs can not only lead to legal action, but also poses a significant public health concern — particularly for those agents that have been previously 'grandfathered' into the system. Once an FDA-approved formulation becomes available, early adoption is key for financial peace of mind, patient safety, and quality healthcare delivery. Continued use of non-approved drugs when a safe, FDA-approved product is available is not in the public interest and can lead to legal lawsuits.” — Cindy Ippoliti, Pharm.D., NYP/Weill Cornell
Contact Information
Expect Advertising, Inc.
Ravi Sachdev
(973) 777-8886 Ext. 101
Contact
www.expectad.com

Click here to view the list of recent Press Releases from Expect Advertising, Inc.
Promote Your Business